Person

Kristen Ambrose

SVP & Chief Accounting Officer, Vertex Pharmaceuticals

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$4.9M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Feb 26, 2026VRTXSale357$483.36$173K
Feb 25, 2026VRTXSale223$486.35$108K
Feb 18, 2026VRTXSale638$473.68$302K
Feb 17, 2026VRTXSale1,557$489.46$762K
Feb 11, 2026VRTXSale1,376$460.43$634K
Feb 25, 2025VRTXSale884$480.95$425K
Feb 18, 2025VRTXSale671$455.06$305K
Feb 11, 2025VRTXSale1,376$459.83$633K
Apr 2, 2024VRTXSale240$419.00$101K
Feb 26, 2024VRTXSale883$425.70$376K
Feb 12, 2024VRTXSale1,374$420.24$577K
May 30, 2023VRTXSale289$329.82$95K
Feb 27, 2023VRTXSale42$289.63$12K
Feb 27, 2023VRTXSale183$288.68$53K
Feb 27, 2023VRTXSale982$287.25$282K
Apr 25, 2022VRTXSale104$271.68$28K
Apr 25, 2022VRTXSale80$268.46$21K
Apr 25, 2022VRTXSale60$267.37$16K
Apr 25, 2022VRTXSale83$269.51$22K

SEC reporting-owner ID (CIK) 1856587 · all filings on EDGAR